Danaher Corporation $DHR Shares Sold by Roundview Capital LLC

Roundview Capital LLC lowered its stake in Danaher Corporation (NYSE:DHR) by 54.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,476 shares of the conglomerate’s stock after selling 18,224 shares during the period. Roundview Capital LLC’s holdings in Danaher were worth $3,057,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. KLP Kapitalforvaltning AS grew its position in Danaher by 2.6% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 234,751 shares of the conglomerate’s stock valued at $46,437,000 after buying an additional 6,000 shares during the last quarter. Hardy Reed LLC lifted its stake in shares of Danaher by 8.2% in the 2nd quarter. Hardy Reed LLC now owns 8,184 shares of the conglomerate’s stock worth $1,617,000 after acquiring an additional 621 shares during the period. Spear Holdings RSC Ltd boosted its holdings in shares of Danaher by 50.6% in the second quarter. Spear Holdings RSC Ltd now owns 409,384 shares of the conglomerate’s stock valued at $80,870,000 after acquiring an additional 137,484 shares in the last quarter. Capital Advisors Inc. OK increased its stake in shares of Danaher by 1.7% during the second quarter. Capital Advisors Inc. OK now owns 174,322 shares of the conglomerate’s stock worth $34,435,000 after acquiring an additional 2,996 shares during the period. Finally, Red Tortoise LLC raised its holdings in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on DHR shares. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Evercore ISI decreased their price target on Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research report on Tuesday, September 2nd. Bank of America decreased their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Finally, UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $245.91.

Danaher Stock Down 1.6%

Danaher stock opened at $211.65 on Tuesday. The firm has a market capitalization of $151.55 billion, a price-to-earnings ratio of 45.03, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The stock’s fifty day moving average is $200.36 and its two-hundred day moving average is $197.24.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the firm earned $1.72 EPS. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.